A detailed history of True Wealth Design, LLC transactions in Genmab A/S stock. As of the latest transaction made, True Wealth Design, LLC holds 23 shares of GMAB stock, worth $498. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 20 15.0%
Holding current value
$498
Previous $599,000 3.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $75 - $90
3 Added 15.0%
23 $578,000
Q1 2024

May 14, 2024

BUY
$26.43 - $32.77 $158 - $196
6 Added 42.86%
20 $599,000
Q4 2022

Feb 15, 2023

BUY
$33.8 - $47.06 $473 - $658
14 New
14 $593,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.3B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.